(3beta,5beta)-3-{[2,6-Dideoxy-4-O-(beta-D-glucopyranosyl)-beta-D-ribo-hexopyranosyl]oxy}-5,14-dihydroxycard-20(22)-enolide(CAS: 13137-64-9)

This compound (CAS: 13137-64-9) falls under the scope of the REACH regulation in the European Union, which requires manufacturers and importers to register substances with the European Chemicals Agency (ECHA). Additionally, it is classified under the Globally Harmonized System (GHS) and may be subject to specific FDA and EPA regulations in the United States, including requirements for reporting, record-keeping, and reporting accidental releases to authorities.

In synthetic routes, there are alternative reagents that can be used as substitutes. For instance, isomers or analogs such as (+)-Pikosarminolide A could be considered. Additionally, other natural products like (-)-Pikosarminolide A or (-)-Pikosarminolide B might serve as effective alternatives in certain synthetic contexts.

The research trend for this compound (CAS: 13137-64-9) indicates a growing interest in its structural modifications and potential applications in medicinal chemistry. Market trends suggest increased investment in natural product chemistry, with a particular focus on cardiotoxicity studies and the development of new bioactive compounds.

Waste containing (CAS: 13137-64-9) should be collected in appropriate containers and disposed of through professional waste disposal services. Incineration is often recommended to ensure complete destruction of the material. Environmental protection measures must be strictly followed, and authorities must be notified as required by local regulations. Proper labeling and documentation of waste are essential for compliance.